20-32216732-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000375749.8(POFUT1):c.542+11G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0184 in 1,578,646 control chromosomes in the GnomAD database, including 330 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.014 ( 28 hom., cov: 32)
Exomes 𝑓: 0.019 ( 302 hom. )
Consequence
POFUT1
ENST00000375749.8 intron
ENST00000375749.8 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.22
Genes affected
POFUT1 (HGNC:14988): (protein O-fucosyltransferase 1) This gene encodes a member of the glycosyltransferase O-Fuc family. This enzyme adds O-fucose through an O-glycosidic linkage to conserved serine or threonine residues in the epidermal growth factor-like repeats of a number of cell surface and secreted proteins. O-fucose glycans are involved in ligand-induced receptor signaling. Alternative splicing of this gene results in two transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 20-32216732-G-C is Benign according to our data. Variant chr20-32216732-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 1170434.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0142 (2156/152266) while in subpopulation NFE AF= 0.02 (1357/68018). AF 95% confidence interval is 0.0191. There are 28 homozygotes in gnomad4. There are 1108 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 2156 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POFUT1 | NM_015352.2 | c.542+11G>C | intron_variant | ENST00000375749.8 | NP_056167.1 | |||
POFUT1 | NM_172236.2 | c.542+11G>C | intron_variant | NP_758436.1 | ||||
POFUT1 | XM_047440079.1 | c.218+11G>C | intron_variant | XP_047296035.1 | ||||
POFUT1 | XR_007067447.1 | n.604+11G>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POFUT1 | ENST00000375749.8 | c.542+11G>C | intron_variant | 1 | NM_015352.2 | ENSP00000364902 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0142 AC: 2156AN: 152148Hom.: 28 Cov.: 32
GnomAD3 genomes
AF:
AC:
2156
AN:
152148
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0144 AC: 3612AN: 251064Hom.: 43 AF XY: 0.0144 AC XY: 1959AN XY: 135714
GnomAD3 exomes
AF:
AC:
3612
AN:
251064
Hom.:
AF XY:
AC XY:
1959
AN XY:
135714
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0188 AC: 26881AN: 1426380Hom.: 302 Cov.: 25 AF XY: 0.0183 AC XY: 13022AN XY: 711792
GnomAD4 exome
AF:
AC:
26881
AN:
1426380
Hom.:
Cov.:
25
AF XY:
AC XY:
13022
AN XY:
711792
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0142 AC: 2156AN: 152266Hom.: 28 Cov.: 32 AF XY: 0.0149 AC XY: 1108AN XY: 74450
GnomAD4 genome
AF:
AC:
2156
AN:
152266
Hom.:
Cov.:
32
AF XY:
AC XY:
1108
AN XY:
74450
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
7
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 09, 2019 | See Variant Classification Assertion Criteria. - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Dowling-Degos disease 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at